Variant report
Variant | nsv982950 |
---|---|
Chromosome Location | chr11:56543432-56546447 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:3)
- CpG islands (count:61)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:3 , 50 per page) page:
1
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:56545039-56545089 | HCF | heart: | n/a |
2 | chr11:56545039-56545089 | HUVEC | blood vessel: | n/a |
3 | chr11:56545039-56545089 | RPTEC | kidney: | n/a |
4 | chr11:56545039-56545089 | Hela-S3 | cervix: | n/a |
5 | chr11:56545039-56545089 | BE2_C | brain: | n/a |
6 | chr11:56545039-56545089 | A549 | lung: | n/a |
7 | chr11:56545039-56545089 | CMK | blood: | n/a |
8 | chr11:56545039-56545089 | U87 | brain: | n/a |
9 | chr11:56545039-56545089 | GM06990 | blood: | n/a |
10 | chr11:56545039-56545089 | GM12891 | blood: | n/a |
11 | chr11:56545039-56545089 | AG09319 | gingival: | n/a |
12 | chr11:56545039-56545089 | NT2-D1 | testis: | n/a |
13 | chr11:56545039-56545089 | AG10803 | skin: | n/a |
14 | chr11:56545039-56545089 | NHDF-neo | bronchial: | n/a |
15 | chr11:56545039-56545089 | AG04450 | lung: | fetal |
16 | chr11:56545039-56545089 | MCF10A-Er-Src | breast: | n/a |
17 | chr11:56545039-56545089 | LNCaP | prostate: | n/a |
18 | chr11:56545039-56545089 | SK-N-SH | brain: | n/a |
19 | chr11:56545039-56545089 | HMEC | breast: | n/a |
20 | chr11:56545039-56545089 | IMR90 | lung: | fetal |
21 | chr11:56545039-56545089 | ECC-1 | luminal epithelium: | n/a |
22 | chr11:56545039-56545089 | HIPEpiC | eye: | n/a |
23 | chr11:56545039-56545089 | PANC-1 | pancreas: | n/a |
24 | chr11:56545039-56545089 | Jurkat | blood: | n/a |
25 | chr11:56545039-56545089 | Caco-2 | colon: | n/a |
26 | chr11:56545039-56545089 | HEEpiC | esophagus: | n/a |
27 | chr11:56545039-56545089 | AoSMC | blood vessel: | n/a |
28 | chr11:56545039-56545089 | ovcar-3 | ovarian: | n/a |
29 | chr11:56545039-56545089 | SK-N-MC | brain: | n/a |
30 | chr11:56545039-56545089 | HCM | heart: | n/a |
31 | chr11:56545039-56545089 | GM12892 | blood: | n/a |
32 | chr11:56545039-56545089 | K562 | blood: | n/a |
33 | chr11:56545039-56545089 | GM12878 | blood: | n/a |
34 | chr11:56545039-56545089 | T-47D | breast: | n/a |
35 | chr11:56545039-56545089 | Hepatocyte | liver: | n/a |
36 | chr11:56545039-56545089 | HCPEpiC | choroid plexus: | n/a |
37 | chr11:56545039-56545089 | AG09309 | skin: | n/a |
38 | chr11:56545039-56545089 | HPAEpiC | pulmonary alveolar: | n/a |
39 | chr11:56545039-56545089 | H1-hESC | embryonic stem cell: | embryo |
40 | chr11:56545039-56545089 | BJ | skin: | n/a |
41 | chr11:56545039-56545089 | HCT-116 | colon: | n/a |
42 | chr11:56545039-56545089 | AG04449 | skin: | fetal |
43 | chr11:56545039-56545089 | NHBE | bronchial: | n/a |
44 | chr11:56545039-56545089 | HL-60 | blood: | n/a |
45 | chr11:56545039-56545089 | NH-A | brain: | n/a |
46 | chr11:56545039-56545089 | SAEC | small airway: | n/a |
47 | chr11:56545039-56545089 | HAEpiC | amniotic membrane: | n/a |
48 | chr11:56545039-56545089 | PrEC | prostate: | n/a |
49 | chr11:56545039-56545089 | GM19239 | blood: | n/a |
50 | chr11:56545039-56545089 | HRPEpiC | eye: | n/a |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
OR5G1P | TF binding region |
OR5G1P | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs12416731 | chr11:56543612-56543613 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs547537034 | chr11:56543658-56543659 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs139577449 | chr11:56543690-56543691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs576131949 | chr11:56543702-56543703 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs368215398 | chr11:56543736-56543737 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs187802053 | chr11:56543748-56543749 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs61902517 | chr11:56543773-56543774 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs532808914 | chr11:56543779-56543780 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs150302709 | chr11:56543823-56543824 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs559675174 | chr11:56543892-56543893 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs530240433 | chr11:56544006-56544007 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs548414835 | chr11:56544007-56544008 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs1015195 | chr11:56544017-56544018 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
14 | rs192331662 | chr11:56544073-56544074 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs552104212 | chr11:56544100-56544101 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs560033914 | chr11:56544176-56544177 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs571252882 | chr11:56544211-56544212 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs538548670 | chr11:56544225-56544226 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs553969448 | chr11:56544293-56544294 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs565718608 | chr11:56544295-56544296 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs184489436 | chr11:56544299-56544300 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs565834207 | chr11:56544309-56544310 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs188702932 | chr11:56544324-56544325 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs192815204 | chr11:56544333-56544334 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs199673407 | chr11:56544387-56544388 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs147571564 | chr11:56544421-56544422 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs141939018 | chr11:56544434-56544435 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs577644254 | chr11:56544517-56544518 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs12786794 | chr11:56544584-56544585 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs77806888 | chr11:56544672-56544673 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs77981034 | chr11:56544689-56544690 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs184420528 | chr11:56544704-56544705 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs34055124 | chr11:56544727-56544728 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs518385 | chr11:56544745-56544746 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
35 | rs12787988 | chr11:56544761-56544762 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs56255728 | chr11:56544766-56544767 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs34699801 | chr11:56544768-56544769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs570498700 | chr11:56544795-56544796 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs138717667 | chr11:56544819-56544820 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs547397137 | chr11:56544881-56544882 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs374565757 | chr11:56544898-56544899 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs548402459 | chr11:56544915-56544916 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs148879732 | chr11:56544924-56544925 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs372169319 | chr11:56544950-56544951 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs536069667 | chr11:56544958-56544959 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs143527035 | chr11:56544976-56544977 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs569816885 | chr11:56545012-56545013 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs537136343 | chr11:56545045-56545046 | Enhancers Weak transcription | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs558611971 | chr11:56545080-56545081 | Enhancers Weak transcription | CpG island | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs576782263 | chr11:56545102-56545103 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 22495311 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Breast cancer | 21364760 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Pituitary adenoma | 18645599 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Smith-Lemli-Opitz syndrome | 21572526 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Breast cancer | 17142309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:56543600-56544200 | Enhancers | Fetal Intestine Small | intestine |
2 | chr11:56543800-56544400 | Enhancers | Fetal Intestine Large | intestine |
3 | chr11:56544200-56545200 | Weak transcription | Fetal Intestine Small | intestine |
4 | chr11:56544400-56544800 | Weak transcription | Fetal Intestine Large | intestine |
5 | chr11:56544800-56545200 | Enhancers | Fetal Intestine Large | intestine |
6 | chr11:56545200-56545400 | Enhancers | Fetal Intestine Small | intestine |
7 | chr11:56545200-56546200 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
8 | chr11:56545400-56546200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
9 | chr11:56545600-56546200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
10 | chr11:56546200-56550200 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
11 | chr11:56546200-56550600 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |